These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6063004)

  • 21. Some effects of chlorambucil on the chromatin of Yoshida ascites sarcoma cells.
    Riches PG; Harrap KR
    Cancer Res; 1973 Feb; 33(2):389-93. PubMed ID: 4688885
    [No Abstract]   [Full Text] [Related]  

  • 22. The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy.
    Harrap KR; Hill BT
    Br J Cancer; 1969 Mar; 23(1):210-26. PubMed ID: 5768437
    [No Abstract]   [Full Text] [Related]  

  • 23. [New nitrogen mustard phosphamide esters and their cytostatic activity].
    Brock N
    Laval Med; 1968 Oct; 39(8):696-701. PubMed ID: 5748235
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sarcolysin binding by histones of Yoshida sarcoma lines resistant and sensitive to alkylating agents].
    Panosian GA
    Biull Eksp Biol Med; 1973 Dec; 76(12):67-70. PubMed ID: 4798656
    [No Abstract]   [Full Text] [Related]  

  • 25. A study on the effect of hyperbaric oxygenation on Yoshida sarcoma, especially on its influence on generation time.
    Osada T
    Nagoya J Med Sci; 1968 Sep; 31(2):243-76. PubMed ID: 5716339
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. II].
    Venuti A; Gioffre' MA; Micali B; Caputo G
    Chir Patol Sper; 1982 Aug; 29(4):167-71. PubMed ID: 7172846
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Abrus precatorius L. on experimental tumors.
    Reddy VV; Sirsi M
    Cancer Res; 1969 Jul; 29(7):1447-51. PubMed ID: 5799161
    [No Abstract]   [Full Text] [Related]  

  • 28. The degree and stability of resistance of a nitrogen mustard-resistant subline of Yoshida tumour.
    Ujházy V; Winkler A
    Folia Biol (Praha); 1965; 11(6):434-7. PubMed ID: 5864752
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental study and clinical application of the effect of Anadrol on cancer bearing organisms].
    Ichihashi H; Ookubo K; Kondo T
    Saishin Igaku; 1966 Oct; 21(10):2312-6. PubMed ID: 5981324
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of the combined treatment of radiation and carcinostatic agents on Yoshida sarcoma cells.
    Adachi T; Saito T
    Bull Tokyo Med Dent Univ; 1966 Dec; 13(4):445-66. PubMed ID: 5234383
    [No Abstract]   [Full Text] [Related]  

  • 31. [Macromomycin--a cytostatic agent acting on the plasma membrane of tumor cells].
    Roth J
    Hippokrates; 1974 May; 45(2):262-3. PubMed ID: 4858632
    [No Abstract]   [Full Text] [Related]  

  • 32. Antitumor effectiveness of improsulfan on nitrogen mustard-resistant Yoshida sarcoma cells.
    Okumoto T; Sugimoto N; Imamura H
    Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):3003-8. PubMed ID: 203408
    [No Abstract]   [Full Text] [Related]  

  • 33. The estimation of human tumors sensitivity to cytostatic treatment. II. The influencing of 125-I iododeoxyuridine incorporation by cytostatics in experimental tumors.
    Andrýsek O; Motycka K; Dvorák O; Jandová A; Stránská E
    Neoplasma; 1969; 16(1):57-61. PubMed ID: 5786510
    [No Abstract]   [Full Text] [Related]  

  • 34. Estimation of sensitivity of human tumors to cytostatics in vitro. I.
    Andrysek O; Jandová A; Motycka K; Slavík K
    Neoplasma; 1968; 15(1):59-69. PubMed ID: 5650630
    [No Abstract]   [Full Text] [Related]  

  • 35. [Incorporation of H3-thymidine into the DNA of cells of surviving slices of transplantable tumors, sensitive and resistant to sarcolysine].
    Merkulov MF; Shelaputina ZF; Iavorskaia NP; Leskova SG
    Farmakol Toksikol; 1970; 33(6):715-23. PubMed ID: 5518494
    [No Abstract]   [Full Text] [Related]  

  • 36. [Selective effect of N,N-bis-(2-chloroethyl)-N1,O-propylenephosphoric acid ester-diamide and analogues on the CAM-tumor system].
    Rauen HM; Norpoth K; Sunder-Plassmann A
    Arzneimittelforschung; 1968 Jan; 18(1):105-9. PubMed ID: 5754936
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. I].
    Venuti A; Fimiani V; Gioffre' MA; Micali B
    Chir Patol Sper; 1982 Aug; 29(4):161-6. PubMed ID: 7172845
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental tumor therapy by regional perfusion. II. The possible role of host resistance against metastatic lesions after regional perfusion.
    Okai K
    J Bone Joint Surg Am; 1967 Oct; 49(7):1337-44. PubMed ID: 6053697
    [No Abstract]   [Full Text] [Related]  

  • 39. Identical karyotypes in acquired drug-resistant sublines of Yoshida sarcoma.
    Ujhåzy V
    Neoplasma; 1974; 21(6):665-9. PubMed ID: 4444746
    [No Abstract]   [Full Text] [Related]  

  • 40. Mode of action of a purified antitumor protein from the proteinaceous crystal of Baccillus thuringiensis subsp. thuringiensis on Yoshida ascites sarcoma cells.
    Prasad SS; Shethna YI
    Antimicrob Agents Chemother; 1976 Aug; 10(2):293-8. PubMed ID: 984772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.